2008
DOI: 10.1038/onc.2008.148
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

8
59
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(67 citation statements)
references
References 35 publications
8
59
0
Order By: Relevance
“…CAM-DR represents a promising approach for pharmacological interventions based on the inhibition of integrin-dependent signaling by statin (Schmidmaier et al, 2004), integrin expression by Bortezomib (Noborio-Hatano et al, 2009) or integrin-ECM binding by small molecules such as FNIII14 interfering with attachment to fibronectin (Matsunaga et al, 2008). Finally, it is important to note that, not only cell-tomatrix, but also cell-to-cell interaction may protect cells against drugs, and that gap-junction poisons, such as carbenoxyolone may act as chemosensitizers (Westhoff et al, 2008).…”
Section: Impact Of Anti-cancer Agents On Integrin Expression and Funcmentioning
confidence: 99%
“…CAM-DR represents a promising approach for pharmacological interventions based on the inhibition of integrin-dependent signaling by statin (Schmidmaier et al, 2004), integrin expression by Bortezomib (Noborio-Hatano et al, 2009) or integrin-ECM binding by small molecules such as FNIII14 interfering with attachment to fibronectin (Matsunaga et al, 2008). Finally, it is important to note that, not only cell-tomatrix, but also cell-to-cell interaction may protect cells against drugs, and that gap-junction poisons, such as carbenoxyolone may act as chemosensitizers (Westhoff et al, 2008).…”
Section: Impact Of Anti-cancer Agents On Integrin Expression and Funcmentioning
confidence: 99%
“…Failure to establish or maintain adherens junctions is also thought to cause apoptosis (Hermiston and Gordon, 1995;Shen and Kramer, 2004). This particular process is still poorly understood and indeed has been difficult to study because of confounding effects from anoikis and additional signals from the local microenvironment (Shen and Kramer, 2004;Westhoff and Fulda, 2009;Westhoff et al, 2008). Finally, disruption of apicobasal polarity can also trigger apoptosis: in Drosophila embryos, removal of apical determinants, such as Crb, Sdt or Baz, leads to widespread cell death (Abrams et al, 1993;Knust et al, 1993;Muller and Wieschaus, 1996;Tepass et al, 1990).…”
Section: Introductionmentioning
confidence: 99%
“…Accordingly, improved treatment strategies, such as the use of TRAIL coupled with other conventional or novel drugs for instance temozolomide (TMZ) [10], paclitaxel, carboplatin and bevacizumab [11], phosphoinositide-3-kinase (PI3K)/ mammalian target of rapamycin (mTOR) inhibitor PI-103 [12], Bortezomib [13], or histone deacetylase inhibitor Entinostat [14], have been explored to enhance the therapeutic efficacy mediated by TRAIL. In gliomas, a study has shown that the use of a gap junction (GJ) inhibitor, carbenoxolone (CBX), was capable of enhancing TRAIL, FasL, and etoposide-induced apoptosis through the disruption of cell-cell interaction [15].…”
Section: Introductionmentioning
confidence: 99%